Hsa-miR-320b also inhibits lung cancer angiogenesis and tumor growth by inhibiting the hepatocyte nuclear factor 4 gamma (HNF4G) and insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) expression (23). Here, IGF2 is linked to neoplasm.